• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清 micro-RNAs 与突变靶向 RNA 修饰:一种使用优化的机器学习工作流程构建的强大癌症检测工具。

Serum micro-RNAs with mutation-targeted RNA modification: a potent cancer detection tool constructed using an optimized machine learning workflow.

机构信息

Department of Hepatobiliary Surgery, The First People's Hospital of Foshan, Foshan, Guangdong Province, China.

General Surgery Center, Department of Hepatobiliary Surgery II, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong Province, China.

出版信息

Sci Rep. 2024 Apr 19;14(1):9016. doi: 10.1038/s41598-024-59480-y.

DOI:10.1038/s41598-024-59480-y
PMID:38641707
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11031599/
Abstract

RNA modifications affect fundamental biological processes and diseases and are a research hotspot. Several micro-RNAs (miRNAs) exhibit genetic variant-targeted RNA modifications that can greatly alter their biofunctions and influence their effect on cancer. Therefore, the potential role of these miRNAs in cancer can be implicated in new prevention and treatment strategies. In this study, we determined whether RMvar-related miRNAs were closely associated with tumorigenesis and identified cancer-specific signatures based on these miRNAs with variants targeting RNA modifications using an optimized machine learning workflow. An effective machine learning workflow, combining least absolute shrinkage and selection operator analyses, recursive feature elimination, and nine types of machine learning algorithms, was used to screen candidate miRNAs from 504 serum RMvar-related miRNAs and construct a diagnostic signature for cancer detection based on 43,047 clinical samples (with an area under the curve value of 0.998, specificity of 93.1%, and sensitivity of 99.3% in the validation cohort). This signature demonstrated a satisfactory diagnostic performance for certain cancers and different conditions, including distinguishing early-stage tumors. Our study revealed the close relationship between RMvar-related miRNAs and tumors and proposed an effective cancer screening tool.

摘要

RNA 修饰影响基本的生物过程和疾病,是研究热点。一些 microRNA(miRNA)表现出针对遗传变异的靶向 RNA 修饰,这极大地改变了它们的生物功能,并影响它们对癌症的影响。因此,这些 miRNA 在癌症中的潜在作用可以被纳入新的预防和治疗策略。在这项研究中,我们确定了 RMvar 相关 miRNA 是否与肿瘤发生密切相关,并基于这些具有靶向 RNA 修饰变异的 miRNA,使用优化的机器学习工作流程,确定了癌症特异性特征。一种有效的机器学习工作流程,结合最小绝对收缩和选择算子分析、递归特征消除和九种机器学习算法,从 504 个血清 RMvar 相关 miRNA 中筛选候选 miRNA,并基于 43047 个临床样本构建癌症检测诊断签名(验证队列的曲线下面积值为 0.998,特异性为 93.1%,灵敏度为 99.3%)。该签名对某些癌症和不同条件(包括区分早期肿瘤)具有令人满意的诊断性能。我们的研究揭示了 RMvar 相关 miRNA 与肿瘤之间的密切关系,并提出了一种有效的癌症筛查工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fa5/11031599/66afd7208ecb/41598_2024_59480_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fa5/11031599/46ccdcdb7430/41598_2024_59480_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fa5/11031599/68ef6387d132/41598_2024_59480_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fa5/11031599/3155080c2abd/41598_2024_59480_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fa5/11031599/df3174462e54/41598_2024_59480_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fa5/11031599/66afd7208ecb/41598_2024_59480_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fa5/11031599/46ccdcdb7430/41598_2024_59480_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fa5/11031599/68ef6387d132/41598_2024_59480_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fa5/11031599/3155080c2abd/41598_2024_59480_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fa5/11031599/df3174462e54/41598_2024_59480_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fa5/11031599/66afd7208ecb/41598_2024_59480_Fig5_HTML.jpg

相似文献

1
Serum micro-RNAs with mutation-targeted RNA modification: a potent cancer detection tool constructed using an optimized machine learning workflow.血清 micro-RNAs 与突变靶向 RNA 修饰:一种使用优化的机器学习工作流程构建的强大癌症检测工具。
Sci Rep. 2024 Apr 19;14(1):9016. doi: 10.1038/s41598-024-59480-y.
2
Constructing diagnostic signature of serum microRNAs using machine learning for early pan-cancer detection.利用机器学习构建血清微小RNA诊断标志物用于早期泛癌检测。
Discov Oncol. 2024 Jul 4;15(1):263. doi: 10.1007/s12672-024-01139-1.
3
Construction of a serum diagnostic signature based on m5C-related miRNAs for cancer detection.基于 m5C 相关 miRNA 的血清诊断标志物构建用于癌症检测。
Front Endocrinol (Lausanne). 2023 Jan 27;14:1099703. doi: 10.3389/fendo.2023.1099703. eCollection 2023.
4
mA target microRNAs in serum for cancer detection.检测癌症的血清中靶 microRNAs。
Mol Cancer. 2021 Dec 20;20(1):170. doi: 10.1186/s12943-021-01477-6.
5
Proposing new early detection indicators for pancreatic cancer: Combining machine learning and neural networks for serum miRNA-based diagnostic model.提出胰腺癌新的早期检测指标:结合机器学习和神经网络构建基于血清miRNA的诊断模型。
Front Oncol. 2023 Aug 3;13:1244578. doi: 10.3389/fonc.2023.1244578. eCollection 2023.
6
Lipid metabolism-related miRNAs with potential diagnostic roles in prostate cancer.与前列腺癌潜在诊断作用相关的脂质代谢 miRNA。
Lipids Health Dis. 2023 Mar 14;22(1):39. doi: 10.1186/s12944-023-01804-4.
7
Automatic discovery of 100-miRNA signature for cancer classification using ensemble feature selection.基于集成特征选择的癌症分类 100-miRNA 标志物的自动发现。
BMC Bioinformatics. 2019 Sep 18;20(1):480. doi: 10.1186/s12859-019-3050-8.
8
Integrated bioinformatics and machine-learning screening for immune-related genes in diagnosing non-alcoholic fatty liver disease with ischemic stroke and RRS1 pan-cancer analysis.整合生物信息学和机器学习筛选免疫相关基因,用于诊断非酒精性脂肪肝合并缺血性脑卒中及 RRS1 泛癌分析。
Front Immunol. 2023 Apr 5;14:1113634. doi: 10.3389/fimmu.2023.1113634. eCollection 2023.
9
RMVar: an updated database of functional variants involved in RNA modifications.RMVar:一个更新的数据库,包含涉及 RNA 修饰的功能变体。
Nucleic Acids Res. 2021 Jan 8;49(D1):D1405-D1412. doi: 10.1093/nar/gkaa811.
10
Signature microRNAs and long noncoding RNAs in laryngeal cancer recurrence identified using a competing endogenous RNA network.基于竞争性内源 RNA 网络的喉癌复发相关特征 microRNAs 和长链非编码 RNA。
Mol Med Rep. 2019 Jun;19(6):4806-4818. doi: 10.3892/mmr.2019.10143. Epub 2019 Apr 10.

本文引用的文献

1
Exosomal noncoding RNAs in prostate cancer.前列腺癌中的细胞外囊泡非编码 RNA
Clin Chim Acta. 2022 Dec 1;537:127-132. doi: 10.1016/j.cca.2022.10.018. Epub 2022 Oct 29.
2
KEGG for taxonomy-based analysis of pathways and genomes.KEGG 用于基于分类的途径和基因组分析。
Nucleic Acids Res. 2023 Jan 6;51(D1):D587-D592. doi: 10.1093/nar/gkac963.
3
Stability of circulating microRNAs in serum.血清中循环微RNA的稳定性
PLoS One. 2022 Aug 31;17(8):e0268958. doi: 10.1371/journal.pone.0268958. eCollection 2022.
4
miRNAs as cornerstones in colorectal cancer pathogenesis and resistance to therapy: A spotlight on signaling pathways interplay - A review.miRNAs 在结直肠癌发病机制和治疗耐药中的基石作用:信号通路相互作用的焦点——综述。
Int J Biol Macromol. 2022 Aug 1;214:583-600. doi: 10.1016/j.ijbiomac.2022.06.134. Epub 2022 Jun 26.
5
The potential role of N-methylguanosine (m7G) in cancer.N-甲基鸟嘌呤(m7G)在癌症中的潜在作用。
J Hematol Oncol. 2022 May 19;15(1):63. doi: 10.1186/s13045-022-01285-5.
6
More than a Bubble: Extracellular Vesicle microRNAs in Head and Neck Squamous Cell Carcinoma.不止是泡沫:头颈部鳞状细胞癌中的细胞外囊泡微小RNA
Cancers (Basel). 2022 Feb 24;14(5):1160. doi: 10.3390/cancers14051160.
7
The ever-increasing importance of cancer as a leading cause of premature death worldwide.癌症作为全球范围内导致过早死亡的主要原因,其重要性日益增加。
Cancer. 2021 Aug 15;127(16):3029-3030. doi: 10.1002/cncr.33587. Epub 2021 Jun 4.
8
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
9
Exosomes and exosomal RNAs in breast cancer: A status update.外泌体及其在乳腺癌中的 RNA :研究进展。
Eur J Cancer. 2021 Feb;144:252-268. doi: 10.1016/j.ejca.2020.11.033. Epub 2020 Dec 26.
10
miRNAs in lung cancer. A systematic review identifies predictive and prognostic miRNA candidates for precision medicine in lung cancer.肺癌中的 microRNAs。一项系统综述确定了用于肺癌精准医学的预测和预后 microRNA 候选物。
Transl Res. 2021 Apr;230:164-196. doi: 10.1016/j.trsl.2020.11.012. Epub 2020 Nov 28.